Novasys secures $49.5 Million in Series D Financing New Data from Renessa Long-Term Durability Trial Presented First Patients Treated in Failed Surgery Clinical Trial InVivo : The Business and Medicine Report, January 2007 edition Novasys Medical to Present at JPMorgan 25th Annual Healthcare Investor Conference Enrollment Complete in Renessa Long Term Durability Study Novasys Medical to Present at Piper Jaffray 18th Annual Health Care Investor Conference 3 Year Evaluation Confirms Long Term Safety and Effectiveness... Novasys Medical named one of MDDIs 50 Companies to Watch Curon & Novasys Announce Intellectual Property Transaction... Novasys Medical Announces New Chief Medical Officer... Novasys Medical Receives FDA Clearance... Novasys Medical Receives Award... Novasys Medical Receives CE Mark...
	Home  |  About Renessa®  |  Clinical  |  News  |  Leadership  |  Contact Us  |  Legal Disclaimer Copyright © 2008 Novasys Medical, Inc. All Rights Reserved.